Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Liyoung Kim, M.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Liyoung Kim's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Liyoung Kim has written about over time.
Histiocytic Necrotizing Lymphadenitis, 1 publications between 2020 and 2020, average publication date August 2020. Lymph Nodes, 1 publications between 2020 and 2020, average publication date August 2020. Lymphadenitis, 1 publications between 2020 and 2020, average publication date August 2020. Child, 2 publications between 2020 and 2024, average publication date August 2022. Humans, 2 publications between 2020 and 2024, average publication date August 2022. Adolescent, 1 publications between 2024 and 2024, average publication date July 2024. Age of Onset, 1 publications between 2024 and 2024, average publication date July 2024. Feasibility Studies, 1 publications between 2024 and 2024, average publication date July 2024. Female, 1 publications between 2024 and 2024, average publication date July 2024. Glucocorticoids, 1 publications between 2024 and 2024, average publication date July 2024. Lupus Erythematosus, Systemic, 1 publications between 2024 and 2024, average publication date July 2024. Male, 1 publications between 2024 and 2024, average publication date July 2024. Retrospective Studies, 1 publications between 2024 and 2024, average publication date July 2024. Risk Factors, 1 publications between 2024 and 2024, average publication date July 2024.

To see the data from this visualization as text, click here.
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.